# FDA Inspection 1261982 - Adare Pharmaceuticals, Inc. - February 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/d31c7419-fc92-4be0-876c-798389f7db7b
Source feed: FDA_Inspections

> FDA Inspection 1261982 for Adare Pharmaceuticals, Inc. on February 25, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261982
- Company Name: Adare Pharmaceuticals, Inc.
- Inspection Date: 2025-02-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Cincinnati District Office

## Related Documents

- [FDA Inspection 1077858 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/4883a301-a05b-44b7-b8d6-ce59448cb6c8)
- [FDA Inspection 1063146 - 2018-07-11](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/bbc06fdb-7c36-4fed-bb67-8be26af648a0)
- [FDA Inspection 1014959 - 2017-05-19](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/7abcafd9-f6da-49aa-a505-293c978f39d3)
- [FDA Inspection 904602 - 2014-11-14](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/436cf7ff-505f-4766-8938-270060dcc47c)
- [FDA Inspection 809244 - 2012-11-16](https://www.keypedia.com/records/fda_inspections/adare-pharmaceuticals-inc/93d2cffa-8aa3-418f-b772-b89df0156a1c)

Company: https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5

Office: https://www.keypedia.com/offices/cincinnati-district-office/b67a0c35-82e3-4176-9039-988378f65c22